Ramsay Générale de Santé Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Ramsay Générale de Santé.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth	23.1%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

No updates

Recent updates

Slowing Rates Of Return At Ramsay Générale de Santé (EPA:GDS) Leave Little Room For Excitement

Nov 19

Here's Why We Think Ramsay Générale de Santé (EPA:GDS) Is Well Worth Watching

Sep 13

Ramsay Générale de Santé (EPA:GDS) Has Some Way To Go To Become A Multi-Bagger

Aug 09

Here's Why I Think Ramsay Générale de Santé (EPA:GDS) Is An Interesting Stock

Jun 02

Return Trends At Ramsay Générale de Santé (EPA:GDS) Aren't Appealing

Mar 29

If You Like EPS Growth Then Check Out Ramsay Générale de Santé (EPA:GDS) Before It's Too Late

Feb 01

Slowing Rates Of Return At Ramsay Générale de Santé (EPA:GDS) Leave Little Room For Excitement

Dec 05

Here's Why We Think Ramsay Générale de Santé (EPA:GDS) Is Well Worth Watching

Oct 30

Is Ramsay Générale de Santé (EPA:GDS) A Risky Investment?

Oct 11

Ramsay Générale de Santé (EPA:GDS) Will Want To Turn Around Its Return Trends

Aug 31

If You Like EPS Growth Then Check Out Ramsay Générale de Santé (EPA:GDS) Before It's Too Late

Jul 15

These 4 Measures Indicate That Ramsay Générale de Santé (EPA:GDS) Is Using Debt Extensively

Jun 15

Ramsay Générale de Santé (EPA:GDS) Will Will Want To Turn Around Its Return Trends

May 04

We Think Ramsay Générale de Santé (EPA:GDS) Is Taking Some Risk With Its Debt

Mar 08

Should We Be Cautious About Ramsay Générale de Santé SA's (EPA:GDS) ROE Of 1.7%?

Feb 15

Should We Be Excited About The Trends Of Returns At Ramsay Générale de Santé (EPA:GDS)?

Jan 19

Should Ramsay Générale de Santé (EPA:GDS) Be Disappointed With Their 19% Profit?

Dec 23

Here's Why Ramsay Générale de Santé's (EPA:GDS) Statutory Earnings Are Arguably Too Conservative

Dec 03

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Ramsay Générale de Santé has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

ENXTPA:GDS - Analysts future estimates and past financials data (EUR Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2023	4,862	-12	398	565	N/A
9/30/2023	4,782	19	412	582	N/A
6/30/2023	4,702	49	427	599	N/A
3/31/2023	4,587	76	336	511	N/A
12/31/2022	4,473	103	246	422	N/A
9/30/2022	4,387	111	157	342	N/A
6/30/2022	4,301	118	69	263	N/A
3/31/2022	4,225	98	7	198	N/A
12/31/2021	4,149	77	-55	133	N/A
9/30/2021	4,086	71	211	393	N/A
6/30/2021	4,023	65	476	652	N/A
3/31/2021	3,873	63	705	875	N/A
12/31/2020	3,723	61	933	1,099	N/A
9/30/2020	3,735	37	747	914	N/A
6/30/2020	3,746	13	561	730	N/A
3/31/2020	3,871	11	338	519	N/A
12/31/2019	3,996	8	116	308	N/A
9/30/2019	3,698	8	76	261	N/A
6/30/2019	3,401	8	36	214	N/A
3/31/2019	2,958	19	45	197	N/A
12/31/2018	2,515	29	54	181	N/A
9/30/2018	2,378	18	103	198	N/A
6/30/2018	2,242	7	151	214	N/A
3/31/2018	2,232	9	142	210	N/A
12/31/2017	2,223	10	132	206	N/A
9/30/2017	2,229	34	N/A	208	N/A
6/30/2017	2,234	57	N/A	209	N/A
3/31/2017	2,262	52	N/A	235	N/A
12/31/2016	2,289	47	N/A	261	N/A
9/30/2016	2,258	42	N/A	228	N/A
6/30/2016	2,227	37	N/A	196	N/A
12/31/2015	1,973	32	N/A	129	N/A
9/30/2015	1,880	21	N/A	152	N/A
6/30/2015	1,722	-3	N/A	184	N/A
12/31/2014	1,712	20	N/A	159	N/A
9/30/2014	1,734	108	N/A	179	N/A
6/30/2014	1,770	112	N/A	139	N/A
3/31/2014	1,820	115	N/A	151	N/A
12/31/2013	1,870	111	N/A	151	N/A
9/30/2013	1,886	40	N/A	163	N/A
6/30/2013	1,897	54	N/A	158	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if GDS's forecast earnings growth is above the savings rate (1.1%).

Earnings vs Market: Insufficient data to determine if GDS's earnings are forecast to grow faster than the French market

High Growth Earnings: Insufficient data to determine if GDS's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if GDS's revenue is forecast to grow faster than the French market.

High Growth Revenue: Insufficient data to determine if GDS's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if GDS's Return on Equity is forecast to be high in 3 years time

Ramsay Générale de Santé Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Recent updates

Ramsay Générale de Santé (EPA:GDS) Seems To Be Using A Lot Of Debt

First half 2024 earnings released: €0.16 loss per share (vs €0.40 profit in 1H 2023)

Investors Interested In Ramsay Générale de Santé SA's (EPA:GDS) Earnings

Full year 2023 earnings released: EPS: €0.45 (vs €1.07 in FY 2022)

Ramsay Générale de Santé (EPA:GDS) Has A Somewhat Strained Balance Sheet

Ramsay Générale de Santé (EPA:GDS) Is Reinvesting At Lower Rates Of Return

New minor risk - Profit margin trend

Does Ramsay Générale de Santé (EPA:GDS) Deserve A Spot On Your Watchlist?

We Think Ramsay Générale de Santé (EPA:GDS) Is Taking Some Risk With Its Debt

The Returns At Ramsay Générale de Santé (EPA:GDS) Aren't Growing

Is Now The Time To Put Ramsay Générale de Santé (EPA:GDS) On Your Watchlist?

Is Ramsay Générale de Santé (EPA:GDS) Using Too Much Debt?

First half 2023 earnings released: EPS: €0.40 (vs €0.54 in 1H 2022)

Returns On Capital At Ramsay Générale de Santé (EPA:GDS) Have Stalled

Does Ramsay Générale de Santé (EPA:GDS) Deserve A Spot On Your Watchlist?

Slowing Rates Of Return At Ramsay Générale de Santé (EPA:GDS) Leave Little Room For Excitement

Less than half of directors are independent

Full year 2022 earnings released: EPS: €1.07 (vs €0.59 in FY 2021)

Ramsay Reportedly Still Weighing Options for French Stake

Here's Why We Think Ramsay Générale de Santé (EPA:GDS) Is Well Worth Watching

Ramsay Générale de Santé (EPA:GDS) Has Some Way To Go To Become A Multi-Bagger

Investor sentiment deteriorated over the past week

Here's Why I Think Ramsay Générale de Santé (EPA:GDS) Is An Interesting Stock

Less than half of directors are independent

Return Trends At Ramsay Générale de Santé (EPA:GDS) Aren't Appealing

If You Like EPS Growth Then Check Out Ramsay Générale de Santé (EPA:GDS) Before It's Too Late

Slowing Rates Of Return At Ramsay Générale de Santé (EPA:GDS) Leave Little Room For Excitement

Full year 2021 earnings released: EPS €0.59 (vs €0.12 in FY 2020)

Here's Why We Think Ramsay Générale de Santé (EPA:GDS) Is Well Worth Watching

Is Ramsay Générale de Santé (EPA:GDS) A Risky Investment?

Ramsay Générale de Santé SA (ENXTPA:GDS) acquired WeCare Holding ApS.

Ramsay Générale de Santé (EPA:GDS) Will Want To Turn Around Its Return Trends

Full year 2021 earnings released: EPS €0.59 (vs €0.12 in FY 2020)

If You Like EPS Growth Then Check Out Ramsay Générale de Santé (EPA:GDS) Before It's Too Late

These 4 Measures Indicate That Ramsay Générale de Santé (EPA:GDS) Is Using Debt Extensively

Ramsay Générale de Santé (EPA:GDS) Will Will Want To Turn Around Its Return Trends

We Think Ramsay Générale de Santé (EPA:GDS) Is Taking Some Risk With Its Debt

New 90-day low: €17.25

Should We Be Cautious About Ramsay Générale de Santé SA's (EPA:GDS) ROE Of 1.7%?

Should We Be Excited About The Trends Of Returns At Ramsay Générale de Santé (EPA:GDS)?

Should Ramsay Générale de Santé (EPA:GDS) Be Disappointed With Their 19% Profit?

Here's Why Ramsay Générale de Santé's (EPA:GDS) Statutory Earnings Are Arguably Too Conservative

Full year earnings released - EPS €0.12

New 90-day high: €18.15

Ramsay Générale de Santé SA (ENXTPA:GDS) acquired Polyclinique Du Parc Drevon from Le Groupe C2S.

Ramsay Générale de Santé SA (ENXTPA:GDS) acquired La Recouvrance.

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies